期刊文献+

补肾健脾活血排毒法治疗慢性肾功能不全随机对照试验的meta分析 被引量:2

Evaluate curative effect of chronic renal failure by methods of Bushen Jianpi Huoxue Paidu
原文传递
导出
摘要 目的:评价补肾健脾活血排毒法中西医结合治疗慢性肾功能不全疗效。方法:检索中国期刊全文数据库(CNKI)、中国生物医学文献数据库(CBM)和中文科技期刊全文数据库(维普),并追查所有纳入研究的参考文献。检索年限从1995-2008年。纳入以补肾健脾活血排毒法为主要组方依据的临床随机对照试验(RCT)。运用Cochrane协作网提供的RevMan4.2分析软件,计数资料计算合并的OR值,计量资料采用WMD和SMD法,并进行显著性检验。结果:治疗组相对于对照组有效率OR=3.82(95%CI,2.72~5.38),P<0.05,血肌酐SMD=-0.72(95%CI,-1.08^-0.35),血尿素氮WMD=-3.32(95%CI,-4.34^-2.29),均P<0.05。结论:研究显示补肾健脾活血排毒原则中西医结合治疗慢性肾功能不全有效,但临床上运用本治法进行临床随机对照试验的研究质量有待提高,应采用严格的设计确保试验结果的可信度。 Objective: The evaluation of curative effect of CRF by Bushen Jianpi Huoxue Paidu and combination western medicine. Method : Gather articles mainly of VIP Information and Wanfang Data of the decade to cure CRF by Bushen Jianpi Huoxue Paidu and combination western medicine with random controlled way, and geostatistical analyse with RevMan4. 2 downloading from Cochrane Collaboration. Result: The control group was 3.82 (95% CI, 2.72 - 5.38 ) , in neurofunction 2 al impairment. The serum creatinine SMD = -0. 72(95%CI, - 1. 08- -0. 35). Urea Nitrogen WMD = -3. 32(95%CI, -4. 34- -2. 29), P 〈0. 05. Conclusion: In addition to the routine treatment, the method of Bushen Jianpi Huoxue Paidu can be used by using some Chinese drugs to enhance the clinical effect.
出处 《中国中药杂志》 CAS CSCD 北大核心 2009年第16期2097-2100,共4页 China Journal of Chinese Materia Medica
基金 江苏省科技厅课题(MB20067i3)
关键词 慢性肾功能不全 中西医结合 补肾健脾 META分析 chronic renal failure, combination of traditional Chinese and western medicine, Bushen Jianpi, meta analysis
  • 相关文献

参考文献12

二级参考文献44

共引文献74

同被引文献34

  • 1魏理.尿毒清颗粒辅助治疗慢性肾功能衰竭疗效的系统评价[J].甘肃中医,2007,20(6):28-30. 被引量:8
  • 2王利军,郭岚,刘冰,等..肾衰竭[M].北京:人民军医出版社,2011.
  • 3Marra G, Silva Y M, Edefonti A C, et al. Comparison of the epidemiology of chronic renal failure (CRF) in low and high-income countries [J]. Clin Nephrol, 2010, 74: S157.
  • 4Terry Feest. Epidemiology and causes of chronic renal failure [J]. Medicine, 2007, 35(8): 438-441.
  • 5Hayata M, Kakizoe Y, Uchimura K, et al. Effect of a serine protease inhibitor on the progression of chronic renal failure [J]. Am J Physiol Renal Physiol, 2012, 303(8): 1126-1135.
  • 6Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement [J]. J Clin Epidemiol, 2009, 62(10): 1006-1012.
  • 7Shea B J, Grimshaw J M, Wells G A, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews [J]. BMC MedRes Methodol, 2007, 7: 10.
  • 8GRADE Working Group. Grading quality of evidence and strength of recommendations [J]. BMJ, 2004, 328(7454): 1490.
  • 9李玫.大黄治疗慢性肾功能衰竭的系统评价[D].成都:四川大学,2001.
  • 10罗杰,冷卫东.系统评价/Meta分析理论与实践[M].北京:军事医学科学出版社,2013.

引证文献2

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部